Showing results (1471-1480 of 5,275) with videos related to
Sort By:
Pageof 528
Oncology|November 24, 2004
Testicular lymphoma: organ-specific treatment did not improve outcomeAgustin Avilés, Natividad Neri, Judith Huerta-Guzmán, et al.Oncology|November 24, 2004
Clinical perspective on desmoplastic small round-cell tumorAlberto Gil, Alberto Gomez Portilla, Erwin A Brun, et al.Oncology|November 24, 2004
Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II studyD Mavroudis, N Malamos, A Polyzos, et al.Oncology|November 24, 2004
Weekly combination of docetaxel and vinorelbine in metastatic breast cancer: a phase I/II studyL Cals, P Nouyrigat, B Valenza, et al.Oncology|November 24, 2004
Expression profiles of a human pancreatic cancer cell line upon induction of apoptosis search for modulators in cancer therapyF Blasco, S Peñuelas, M Cascalló, et al.Oncology|November 24, 2004
Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cellsMasami Niiya, Kenji Niiya, Misako Shibakura, et al.Oncology|June 26, 2004
Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology groupRobert C Shepard, Donna E Levy, Jordan D Berlin, et al.Oncology|June 26, 2004
Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancerFederica Barbieri, Paola Lorenzi, Nicola Ragni, et al.Oncology|June 26, 2004
Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytesOren Shibolet, Ruslana Alper, Lydia Zlotogarov, et al.Oncology|June 26, 2004
Gemcitabine and cisplatin in refractory malignant lymphomaAgustín Avilés, Natividad Neri, Judith Huerta-Guzmán, et al.Pageof 528